Risk biomarkers in Spanish AIDS R&D (research and development) funding :
This article was originally published in Clinica
Executive Summary
Research into biomarkers for assessing the risk of pre-eclampsia and intrauterine foetal death in HIV-infected women is the theme of one of the 22 projects that have been approved for funding under Spain's AIDS research and prevention foundation (FIPSE). Markers for cardiovascular risk as predictors of atherosclerosis linked to HIV infection will also get a share of this year's Euro2.04m ($2.4m) fund. Others include research into the HIV transcription factor CA-150 and monitoring the response of HIV-infected women to anti-retrovirals during pregnancy. This sixth funding round brings FIPSE's total disbursement to date to Euro13.6m, among 149 projects.